SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition Comment

被引:13
作者
Altmann, Daniel M. [1 ]
Reynolds, Catherine J. [2 ]
Boyton, Rosemary J. [2 ,3 ,4 ]
机构
[1] Imperial Coll London, Dept Immunol & Inflammat, London, England
[2] Imperial Coll London, Dept Infect Dis, London, England
[3] Royal Brompton Hosp, Lung Div, London, England
[4] Harefield Hosp, London, England
基金
英国医学研究理事会; 欧盟地平线“2020”;
关键词
D O I
10.1016/j.xcrm.2021.100286
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
COVID-19 variants of concern, including B.1.1.7, B.1.351, and P.1, encompass mutations facilitating immune evasion. Neutralizing antibody recognition and function may be variably impaired. We considered the impact of mutations on T cell responses. Mutations could be neutral or result in either loss or gain of predicted epitopes depending on HLA type.
引用
收藏
页数:3
相关论文
共 14 条
  • [1] SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
    Altmann, Daniel M.
    Boyton, Rosemary J.
    [J]. SCIENCE IMMUNOLOGY, 2020, 5 (49)
  • [2] Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
    Bautista-Vargas, Mario
    Bonilla-Abadia, Fabio
    Canas, Carlos A.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (03) : 479 - 483
  • [3] Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
    Brouwer, Philip J. M.
    Caniels, Tom G.
    van der Straten, Karlijn
    Snitselaar, Jonne L.
    Aldon, Yoann
    Bangaru, Sandhya
    Torres, Jonathan L.
    Okba, Nisreen M. A.
    Claireaux, Mathieu
    Kerster, Gius
    Bentlage, Arthur E. H.
    van Haaren, Marlies M.
    Guerra, Denise
    Burger, Judith A.
    Schermer, Edith E.
    Verheul, Kirsten D.
    van der Velde, Niels
    van der Kooi, Alex
    van Schooten, Jelle
    van Breemen, Marielle J.
    Bijl, Tom P. L.
    Sliepen, Kwinten
    Aartse, Aafke
    Derking, Ronald
    Bontjer, Ilja
    Kootstra, Neeltje A.
    Wiersinga, W. Joost
    Vidarsson, Gestur
    Haagmans, Bart L.
    Ward, Andrew B.
    de Bree, Godelieve J.
    Sanders, Rogier W.
    van Gils, Marit J.
    [J]. SCIENCE, 2020, 369 (6504) : 643 - +
  • [4] Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
    Davies, Nicholas G.
    Abbott, Sam
    Barnard, Rosanna C.
    Jarvis, Christopher, I
    Kucharski, Adam J.
    Munday, James D.
    Pearson, Carl A. B.
    Russell, Timothy W.
    Tully, Damien C.
    Washburne, Alex D.
    Wenseleers, Tom
    Gimma, Amy
    Waites, William
    Wong, Kerry L. M.
    van Zandvoort, Kevin
    Silverman, Justin D.
    Diaz-Ordaz, Karla
    Keogh, Ruth
    Eggo, Rosalind M.
    Funk, Sebastian
    Jit, Mark
    Atkins, Katherine E.
    Edmunds, W. John
    [J]. SCIENCE, 2021, 372 (6538) : 149 - +
  • [5] Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
    Greaney, Allison J.
    Loes, Andrea N.
    Crawford, Katharine H. D.
    Starr, Tyler N.
    Malone, Keara D.
    Chu, Helen Y.
    Bloom, Jesse D.
    [J]. CELL HOST & MICROBE, 2021, 29 (03) : 463 - +
  • [6] Haynes WinstonA., 2020, HIGH RESOLUTION MAPP
  • [7] S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction
    Kidd, Michael
    Richter, Alex
    Best, Angus
    Cumley, Nicola
    Mirza, Jeremy
    Percival, Benita
    Mayhew, Megan
    Megram, Oliver
    Ashford, Fiona
    White, Thomas
    Moles-Garcia, Emma
    Crawford, Liam
    Bosworth, Andrew
    Atabani, Sowsan F.
    Plant, Tim
    McNally, Alan
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (10) : 1666 - 1670
  • [8] Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
    Muik, Alexander
    Wallisch, Ann-Kathrin
    Saenger, Bianca
    Swanson, Kena A.
    Muehl, Julia
    Chen, Wei
    Cai, Hui
    Maurus, Daniel
    Sarkar, Ritu
    Tuereci, Oezlem
    Dormitzer, Philip R.
    Sahin, Ugur
    [J]. SCIENCE, 2021, 371 (6534) : 1152 - +
  • [9] SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
    Nelde, Annika
    Bilich, Tatjana
    Heitmann, Jonas S.
    Maringer, Yacine
    Salih, Helmut R.
    Roerden, Malte
    Luebke, Maren
    Bauer, Jens
    Rieth, Jonas
    Wacker, Marcel
    Peter, Andreas
    Hoerber, Sebastian
    Traenkle, Bjoern
    Kaiser, Philipp D.
    Rothbauer, Ulrich
    Becker, Matthias
    Junker, Daniel
    Krause, Gerard
    Strengert, Monika
    Schneiderhan-Marra, Nicole
    Templin, Markus F.
    Joos, Thomas O.
    Kowalewski, Daniel J.
    Stos-Zweifel, Vlatka
    Fehr, Michael
    Rabsteyn, Armin
    Mirakaj, Valbona
    Karbach, Julia
    Jaeger, Elke
    Graf, Michael
    Gruber, Lena-Christin
    Rachfalski, David
    Preuss, Beate
    Hagelstein, Ilona
    Maerklin, Melanie
    Bakchoul, Tamam
    Gouttefangeas, Cecile
    Kohlbacher, Oliver
    Klein, Reinhild
    Stevanovic, Stefan
    Rammensee, Hans-Georg
    Walz, Juliane S.
    [J]. NATURE IMMUNOLOGY, 2021, 22 (01) : 74 - 85
  • [10] Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
    Reynolds, Catherine J.
    Swadling, Leo
    Gibbons, Joseph M.
    Pade, Corinna
    Jensen, Melanie P.
    Diniz, Mariana O.
    Schmidt, Nathalie M.
    Butler, David K.
    Amin, Oliver E.
    Bailey, Sasha N. L.
    Murray, Sam M.
    Pieper, Franziska P.
    Taylor, Stephen
    Jones, Jessica
    Jones, Meleri
    Lee, Wing-Yiu Jason
    Rosenheim, Joshua
    Chandran, Aneesh
    Joy, George
    Di Genova, Cecilia
    Temperton, Nigel
    Lambourne, Jonathan
    Cutino-Moguel, Teresa
    Andiapen, Mervyn
    Fontana, Marianna
    Smit, Angelique
    Semper, Amanda
    O'Brien, Ben
    Chain, Benjamin
    Brooks, Tim
    Manisty, Charlotte
    Treibel, Thomas
    Moon, James C.
    Noursadeghi, Mahdad
    Altmann, Daniel M.
    Maini, Mala K.
    McKnight, Aine
    Boyton, Rosemary J.
    [J]. SCIENCE IMMUNOLOGY, 2020, 5 (54)